237 Pill - blue & white capsule-shape, 14mm
Pill with imprint 237 is Blue & White, Capsule-shape and has been identified as Ziprasidone Hydrochloride 20 mg. It is supplied by Cadila Healthcare Limited.
Ziprasidone is used in the treatment of Autism; Schizoaffective Disorder; Bipolar Disorder; Schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Ziprasidone 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 237
Ziprasidone Hydrochloride
- Imprint
- 237
- Strength
- 20 mg
- Color
- Blue & White
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70771-1179
- Inactive Ingredients
-
alcohol,
ammonia,
butyl alcohol,
FD&C Blue No. 1,
FD&C Red No. 40,
gelatin,
isopropyl alcohol,
lactose monohydrate,
magnesium stearate,
potassium hydroxide,
propylene glycol,
shellac,
sodium lauryl sulfate,
corn starch,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related images for "237"
More about ziprasidone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (475)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: atypical antipsychotics
- Breastfeeding
- En español
Patient resources
- Ziprasidone drug information
- Ziprasidone (Intramuscular) (Advanced Reading)
- Ziprasidone (Oral) (Advanced Reading)
- Ziprasidone Capsules
- Ziprasidone Injection
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.